Anti-infective Drugs Market

Anti-infective Drugs Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
2018-2026
Infectious diseases are health disorders that are caused by invasion and multiplication of infectioncausing foreign organisms in a host’s body. Growth and multiplication of harmful pathogens such as
bacteria, viruses, fungi, and parasites causes major infections in the host body. Infection can be
transmitted through skin contact, bodily fluids, airborne particles, or touching an infected object. Antiinfective drugs are used for the treatment of infectious diseases or conditions. Anti-infective drugs act
by inhibiting the growth or by eliminating the infectious agents.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/2489
Key players in the market are focused on new product launch, which is expected to boost the antiinfective drugs market growth. For instance, in January 2018, Melinta Therapeutics, Inc. launched its
intravenous and oral formulations of Baxdela (delafloxacin) in the U.S. Baxdela is intended for the
treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by designated
susceptible bacteria including gram positive bacteria and gram negative bacteria.
Anti-infective Drugs Market: Regional Analysis
On the basis of region, the global anti-infective drugs market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to witness significant growth in the anti-infective drugs market over
the forecast period. This is owing increasing expansion activities by key players in this region.
For instance, in September 2018, Xellia Pharmaceuticals, a specialty pharmaceutical company
that offers anti-infective drugs against serious and often life-threatening infections, started its
new office in Buffalo Grove, near Chicago, Illinois to expand its sales and manufacturing
capabilities within the U.S.
Report includes chapters which deeply display the following deliverable about industry :
• Anti-infective Drugs Market Research Objective and Assumption
• Anti-infective Drugs Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Anti-infective Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Anti-infective Drugs Market, By Regions
• Anti-infective Drugs Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Anti-infective Drugs Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Anti-infective Drugs Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Anti-infective Drugs Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the anti-infective drugs market include, Abbott Laboratories, Alcon
Pharmaceuticals Ltd., Astellas Pharma Inc., AstraZeneca Plc., Bayer HealthCare AG, Alkem
Labs, Pacific India Pharma Limited, Pfizer, and others.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2489
Anti-infective Drugs Market Taxonomy
By Drug Class Type
• Anti-bacterial Drugs
• B – Lactams
• Quinolones
• Macrolides
• Tetracycline
• Aminoglycoside
• Others
• Anti-fungal Drugs
• Azoles
• Echinocandins
• Polyenes
• Others
• Anti-viral Drugs
By Indication Type
•
•
•
•
•
•
•
•
•
•
•
Pneumonia
Methicillin-resistant Staphylococcus Aureus (MRSA)
Sepsis
Tuberculosis
Dermatophytosis
Aspergillosis
Candidiasis
Hepatitis Virus Infection
HIV Infection
Respiratory Virus Infection
Others
By Route of Administration
• Oral
• Topical
• Parenteral
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Region
•
•
•
•
•
•
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com